profit from every $100 of sales.
$0$100
Aimei Health Technology
$0.10+0.00% today
-71.4% in 1 year
1-year low $0.081-year high $0.44
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $155.44 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Aimei Health Technology vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Aimei Health Technology | 155.4× · No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Unusual Machines | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Armada Acquisition Corp. II | 348.4× · No profit yet |
AI analysis
An AI analyst reads Aimei Health Technology's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 155.4×
- –
- –
- 20.5×
- 0.0×
- –
- –
- -27.1%
- 0.6%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -7.8%
- 4.8%
- 3.2%
- 8.8%
- -9.6%
- –
Growth
- –
- +199.1%
- +15.9%
- –
- −33.0%
Financial health
- -2.4×
- 0.25
- 16.7%
- –
- 0.00
- 0.00
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 3%of 748
Bottom 8%of 603
Bottom 2%of 873
Bottom 5%of 933
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
25No pass
Benjamin Graham
29No pass
Philip Fisher
43No pass
Peter Lynch
85Pass
Joel Greenblatt
1No pass
Charlie Munger
23No pass
Terry Smith
17No pass
Questions about Aimei Health Technology
Is Aimei Health Technology a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Aimei Health Technology AI analysis
What does Aimei Health Technology do?
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It is in Shell Companies.
Does Aimei Health Technology pay a dividend?
No. Aimei Health Technology does not pay a dividend at the moment.
Is Aimei Health Technology stock halal?
Questionable. Aimei Health Technology sits in a grey zone: scholars disagree about its industry. How we check
How has Aimei Health Technology stock done over the past year?
Down 71.4% over the past twelve months, to $0.10. It traded between $0.08 and $0.44 and is 77.3% below its high.
Who are Aimei Health Technology's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Unusual Machines, Drugs Made In America Acquisition II and Armada Acquisition Corp. II. The peers table on this page compares their profit, growth and price with Aimei Health Technology's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.